Effects of Phenosanic Acid in Rat Seizure Models

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Epilepsy pathogenesis involves oxidative stress and membrane damage.
• Phenosanic acid (PA) is an antioxidant and membrane protector.
• Investigating PA's therapeutic potential in epilepsy models is warranted.

Purpose of the Study:

• To evaluate the anti-seizure and disease-modifying effects of phenosanic acid (PA).
• To assess PA's impact on oxidative stress, the hypothalamo-pituitary-adrenocortical axis, and neurogenesis in epilepsy models.

Main Methods:

• Utilized pentylenetetrazole (PTZ) and lithium-pilocarpine-induced seizure models in male Wistar rats.
• Administered PA acutely and chronically via intraperitoneal and oral routes.
• Assessed oxidative stress markers, corticosterone levels, and hippocampal neurogenesis (PCNA+, DCX+).

Main Results:

• PA demonstrated acute anti-seizure activity in the PTZ model.
• Acute PA treatment reduced mortality and corticosterone levels in the lithium-pilocarpine model.
• Chronic PA treatment decreased oxidative stress markers and increased Doublecortin positive (DCX+) cells, suggesting effects on neurogenesis.

Conclusions:

• Phenosanic acid (PA) exhibits potential as a disease-modifying anti-epileptic drug (AED).
• PA's efficacy may involve reducing lipid peroxidation and corticosterone levels.
• Chronic PA treatment could modulate adult hippocampal neurogenesis, potentially hindering epileptogenesis.